Wilmington Savings Fund Society FSB Sells 5,149 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Wilmington Savings Fund Society FSB lessened its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 94,806 shares of the medical instruments supplier’s stock after selling 5,149 shares during the quarter. Wilmington Savings Fund Society FSB owned approximately 0.16% of Merit Medical Systems worth $9,170,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the company. FMR LLC lifted its position in shares of Merit Medical Systems by 70.1% during the 3rd quarter. FMR LLC now owns 1,577,246 shares of the medical instruments supplier’s stock valued at $155,879,000 after buying an additional 649,799 shares during the last quarter. Two Sigma Advisers LP boosted its position in Merit Medical Systems by 218.9% during the third quarter. Two Sigma Advisers LP now owns 445,500 shares of the medical instruments supplier’s stock worth $44,029,000 after purchasing an additional 305,800 shares during the period. JPMorgan Chase & Co. boosted its position in Merit Medical Systems by 85.6% during the third quarter. JPMorgan Chase & Co. now owns 575,946 shares of the medical instruments supplier’s stock worth $56,921,000 after purchasing an additional 265,648 shares during the period. Iron Triangle Partners LP purchased a new position in shares of Merit Medical Systems in the third quarter worth about $25,004,000. Finally, International Assets Investment Management LLC purchased a new stake in shares of Merit Medical Systems during the 3rd quarter valued at approximately $21,156,000. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Price Performance

Shares of NASDAQ:MMSI opened at $109.12 on Friday. Merit Medical Systems, Inc. has a one year low of $70.70 and a one year high of $111.45. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. The firm has a market capitalization of $6.36 billion, a price-to-earnings ratio of 53.49, a PEG ratio of 2.42 and a beta of 0.87. The company’s fifty day moving average price is $101.88 and its 200-day moving average price is $97.91.

Analyst Ratings Changes

A number of research firms recently weighed in on MMSI. Wells Fargo & Company upgraded shares of Merit Medical Systems from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $103.00 to $120.00 in a research note on Wednesday, December 11th. Robert W. Baird lifted their price target on Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Piper Sandler reissued an “overweight” rating and set a $116.00 price objective (up previously from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Barrington Research lifted their target price on Merit Medical Systems from $114.00 to $115.00 and gave the company an “outperform” rating in a report on Wednesday, January 29th. Finally, Needham & Company LLC upped their price target on Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $109.80.

Insider Buying and Selling at Merit Medical Systems

In other news, Director F. Ann Millner sold 12,500 shares of the business’s stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.55, for a total value of $1,269,375.00. Following the completion of the sale, the director now directly owns 32,391 shares in the company, valued at approximately $3,289,306.05. The trade was a 27.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 3.70% of the company’s stock.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.